Commentary: Substandard medicines are the priority for neglected tropical diseases
BMJ
.
2012 Nov 14;345:e7518.
doi: 10.1136/bmj.e7518.
Authors
Thomas P C Dorlo
1
,
Raffaella M Ravinetto
,
Jos H Beijnen
,
Marleen Boelaert
Affiliation
1
Department of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute, Amsterdam, Netherlands. thomas.dorlo@slz.nl
PMID:
23152570
DOI:
10.1136/bmj.e7518
No abstract available
Publication types
Comment
MeSH terms
Counterfeit Drugs*
Fraud / prevention & control*
International Cooperation*
Substances
Counterfeit Drugs